https://www.selleckchem.com/pr....oducts/anisomycin.ht
To assess the cost-effectiveness of management strategies for patients presenting with chest pain and suspected coronary heart disease (CHD) (1) cardiovascular magnetic resonance (CMR); (2) myocardial perfusion scintigraphy (MPS); and (3) UK National Institute for Health and Care Excellence (NICE) guideline-guided care. Using UK data for 1202 patients from the Clinical Evaluation of Magnetic Resonance Imaging in Coronary Heart Disease 2 trial, we conducted an economic evaluation to assess the cost-effectiveness of CMR, MPS and NICE g